Incidence and mechanisms of longitudinal stent deformation associated with Biomatrix, Resolute, Element, and Xience stents: Angiographic and case-by-case review of 1,800 PCIs
Autor: | Bernard Clarke, Farzin-Farth Ordoubadi, Nizar Shakhshir, Vaikom Mahadavan, Paul D. Williams, Mamas A. Mamas, Magdi El-Omar, Samer Arnous, Douglas G. Fraser, Andrew Wiper |
---|---|
Rok vydání: | 2015 |
Předmět: |
medicine.medical_specialty
Guide catheter business.industry medicine.medical_treatment Incidence (epidemiology) Percutaneous coronary intervention Stent General Medicine Stent deformation Culprit Case review Surgery Conventional PCI Medicine Radiology Nuclear Medicine and imaging Cardiology and Cardiovascular Medicine business |
Zdroj: | Catheterization and Cardiovascular Interventions. 86:1002-1011 |
ISSN: | 1522-1946 |
DOI: | 10.1002/ccd.25790 |
Popis: | Background There is conflicting evidence regarding the incidence of longitudinal stent deformation (LSD) in contemporary practice. Methods and results To assess the incidence and mechanism of LSD across commonly used DES platforms, we performed a case-by-case review of 1,800 PCI cases involving 450 consecutive procedures using Biomatrix Flex, Resolute Integrity, Promus Element and Xience V stents respectively, between Jan 2009-December 2011. LSD was detected in a higher proportion with Promus Element [15 (3.1%)] compared to other platforms (Xience V [4(0.9%)], Biomatrix [3 (0.7%)], Resolute [3 (0.7%)];p=0.002). LSD was characterised as guide catheter / guide extension induced, or as impact from secondary devices such as post-dilatation balloons or IVUS catheters. The incidence of guide catheter/guide extension LSD was similar across platforms; (Promus Element [5 (1.1%)], Xience V [4 (0.9%)], Biomatrix [3(0.7%)], Resolute [3 (0.7%)]; p=0.85). Secondary device LSD occurred exclusively with Promus Element (9/450 cases [2%] (p |
Databáze: | OpenAIRE |
Externí odkaz: |